Investigating how Dynorphin affects insulin secretion and glucose regulation
Dynorphin, a novel paracrine factor that regulates insulin secretion
This study is looking at how a molecule called Dynorphin affects insulin release from pancreatic cells, which could help us find new ways to improve blood sugar control for people with type 2 diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-11064892 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of Dynorphin, a signaling molecule, in regulating insulin secretion from pancreatic cells. By studying the interactions between different types of cells in the pancreas, the research aims to uncover how these signals contribute to maintaining healthy blood sugar levels. The approach involves both mouse and human pancreatic cells to assess how Dynorphin influences insulin release and glucose homeostasis, particularly in conditions like type 2 diabetes. The ultimate goal is to identify new targets for improving insulin secretion in patients with insulin resistance.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with type 2 diabetes or those at risk of developing insulin resistance.
Not a fit: Patients with type 1 diabetes or those without any insulin regulation issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance insulin secretion and improve blood sugar control in patients with diabetes.
How similar studies have performed: Previous research has shown promising results in understanding paracrine signaling in pancreatic cells, indicating potential for success in this novel approach.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Blandino-Rosano, Manuel — University of Miami School of Medicine
- Study coordinator: Blandino-Rosano, Manuel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.